起效快？拜瑞妥能溶掉血栓吗？拜瑞妥吃多久血栓可以消失？

Xarelto is a new anticoagulant drug that is rapidly absorbed after oral administration, with an average half-life of 7 to 13 hours. Xarelto has the advantages of high bioavailability, stable anticoagulant effect, high selectivity, and obvious therapeutic effect. Patients can benefit greatly from taking this drug consistently. Under normal circumstances, as long as there are no obvious contraindications and the instructions are strictly followed or the doctor's advice is followed, patients with indications can use Xarelto for a long time. Does the treatment work quickly for patients? Can Xarelto dissolve blood clots? How long does it take for blood clots to disappear after taking Xarelto?

Xarelto effective time

Since each patient's disease stage and personal constitution are different, the time it takes for the patient to take effect after receiving Xarelto treatment and whether the blood clot will disappear and the time it takes to disappear are all different. This is determined by the patient's disease stage and personal constitution.

Xarelto’s effectiveness in treating blood clots

As an oral factor In clinical practice, Xarelto can dissolve thrombus, but it cannot directly remove thrombus. However, in a sense, it also removes thrombus indirectly.

  In a randomized, double-blind, controlled study, the clinical trial was divided into 3 groups. The first group of 1107 patients took 20 mg of Xarelto, the second group of 1127 patients took 10 mg of Xarelto, and the third group of 1131 patients took 100 mg of aspirin. These patients had completed 6 to 12 months of initial anticoagulant therapy.

  After 12 months of continuous use, the recurrence rate of venous thrombosis in the aspirin group was 4.4%. The recurrence rates of Xarelto 20 mg and 10 mg were significantly lower than those in the aspirin group, which were 1.5% and 1.2% respectively. Comparing the three groups, there were very few patients who experienced severe bleeding after taking the drug, which were 0.3%, 0.4% and 0.5% respectively. There was no statistical difference between the three groups. The clinically relevant non-bleeding events between the 3 groups were 2.7, 2.0, and 1.8 respectively, and there was also no statistical difference.

Conclusion: For patients with venous thrombosis who have completed 6 to 12 months of treatment and need to continue treatment and who are clinically in equilibrium, Xarelto 20 mg or 10 mg continued anticoagulation for the treatment of venous thromboembolism is more effective than 100 mg aspirin, with a significantly lower recurrence rate than aspirin, and does not increase the incidence of bleeding. It also confirmed the feasibility of low-dose Xarelto (10 mg) in the treatment of venous thromboembolism.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended hot articles: